根据北京康乐卫士生物技术股份有限公司（以下简称"公司"）整体经营规 划和管理需要，为进一步优化资源配置，降低管理成本，公司于 2025 年 8 月 21 日召开第五届董事会第十一次会议，审议通过了《关于注销分公司的议案》，公 司董事会同意注销北京康乐卫士生物技术股份有限公司南京分公司（以下简称 "南京分公司"）、北京康乐卫士生物技术股份有限公司昆明分公司（以下简称 "昆明分公司"），并授权公司管理层办理上述分公司注销等相关事宜。 本次注销分公司不涉及关联交易，亦不构成《上市公司重大资产重组管理办 法》规定的重大资产重组。本次注销分公司在公司董事会审批权限范围内，无需 提交股东会审议。 二、拟注销分公司的基本情况 证券代码：833575 证券简称：康乐卫士 公告编号：2025-089 北京康乐卫士生物技术股份有限公司 关于注销分公司的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 法律责任。 一、基本情况 （一）南京分公司 公司类型：其他股份有限公司分公司（上市） 公司名称：北京康乐卫士生物技术股份有限公司南京 ...

北京康乐卫士生物技术股份有限公司 证券代码：833575 证券简称：康乐卫士 公告编号：2025-090 关于全资子公司增资扩股的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、本次交易概述 北京康乐卫士生物技术股份有限公司（以下简称"公司"）于 2025 年 1 月 24 日召开了第五届董事会 2025 年第一次独立董事专门会议、第五届董事会第五 次会议、第五届监事会第五次会议，审议通过了《关于全资子公司增资扩股暨关 联方提供担保的议案》。公司全资子公司康乐卫士（昆明）生物技术有限公司（以 下简称"昆明康乐"）以增资扩股方式进行股权融资，昆明市创新创业产业发展 股权投资基金合伙企业（有限合伙）（以下简称"双创基金"）、云南烁锦投资有 限公司（以下简称"烁锦投资"）以货币方式向昆明康乐合计增资 14,950 万元， 认购昆明康乐新增注册资本合计 2,412.06 万元（以下简称"本次增资"或"本次 交易"）。其中双创基金以 10,000 万元认购昆明康乐新增注册资本 1,613.42 万元 ...

北京康乐卫士生物技术股份有限公司 2025 年半年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、募集资金基本情况 （一）募集资金数额及资金到账时间 北京康乐卫士生物技术股份有限公司（"本公司"或"公司"）自新三板挂 牌及北京证券交易所（以下简称"北交所"）上市以来共计完成五次募集资金计 划，其中，2019 年新三板第一次股票发行和 2019 年新三板第二次股票发行募集 资金已于 2022 年 12 月 31 日之前全部使用完毕，2020 年新三板第一次股票定向 发行募集资金已于 2024 年 12 月 31 日之前全部使用完毕。2025 年半年度本公司 存续的募集资金共两次，具体情况如下： 证券代码：833575 证券简称：康乐卫士 公告编号：2025-086 1、2023 年北交所公开发行募集资金 2023 年 1 月 20 日，中国证券监督管理委员会下发《关于同意北京康乐卫士 生物技术股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监许 可〔2 ...

一、会议召开和出席情况 （一）会议召开情况 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合相关法律、行政法规、部门规章、 规范性文件和《公司章程》等有关规定。 （二）会议出席情况 证券代码：833575 证券简称：康乐卫士 公告编号：2025-088 北京康乐卫士生物技术股份有限公司 第五届监事会第十一次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于公司 2025 年半年度报告及其摘要的议案》 1.议案内容： 公司根据北京证券交易所的相关规定编制了 2025 年半年度报告及其摘要。 具体内容详见公司同日在北京证券交易所信息披露平台（www.bse.cn）披露 1.会议召开时间：2025 年 8 月 21 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯相结合的方式 4.发出监事会会议通知的时间和方式：2025 年 8 月 11 日以邮件和电话方式发出 ...

证券代码：833575 证券简称：康乐卫士 公告编号：2025-087 北京康乐卫士生物技术股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 8 月 21 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯相结合的方式 4.发出董事会会议通知的时间和方式：2025 年 8 月 11 日以邮件和电话方式 发出 5.会议主持人：董事长刘永江先生 6.会议列席人员：部分监事、高级管理人员 第五届董事会第十一次会议决议公告 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合相关法律、行政法规、部门规章、 规范性文件和《公司章程》等有关规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 二、议案审议情况 （一）审议通过《关于公司 2025 年半年度报告及其摘要的议案》 1.议案内容： 公司根据北京证券交易所的相关规定编制了 2025 年半年度报告及其摘要。 ...

Market Overview - The Shanghai Composite Index closed at 3771.10 points, above the annual line, with a change of 0.13% [1] - The total trading volume of A-shares reached 24603.35 billion yuan [1] Stocks Breaking Annual Line - A total of 28 A-shares have surpassed the annual line today, with notable stocks including: - Meihua Medical (301363) with a deviation rate of 14.81% and a daily increase of 18.00% [1] - Meirui New Materials (300848) with a deviation rate of 4.67% and a daily increase of 5.49% [1] - Kangle Health (833575) with a deviation rate of 4.29% and a daily increase of 4.40% [1] Stocks with Smaller Deviation Rates - Stocks that have just crossed the annual line with smaller deviation rates include: - Guotou Power (600886) with a deviation rate of 0.01% and a daily increase of 1.30% [2] - Shanghai Pharmaceuticals (601607) with a deviation rate of 0.08% and a daily increase of 0.95% [2] - *ST Jinglun (600355) with a deviation rate of 0.20% and a daily increase of 0.86% [2]

Market Overview - The Shanghai Composite Index is at 3777.53 points, above the annual line, with a change of 0.30% [1] - The total trading volume of A-shares today is 1,949.327 billion yuan [1] Stocks Breaking Annual Line - A total of 28 A-shares have broken above the annual line today [1] - Notable stocks with significant deviation rates include: - Meihua Medical: 13.20% - Changhong Meiling: 3.88% - Kangle Weishi: 3.73% [1] Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Spring Airlines: 0.02% - Qingdao Port: 0.07% - Shanghai Pharmaceuticals: 0.08% [2] Performance of Selected Stocks - Meihua Medical shows a daily increase of 16.34% with a turnover rate of 29.76% [1] - Changhong Meiling has increased by 5.74% with a turnover rate of 6.32% [1] - Kangle Weishi has risen by 3.83% with a turnover rate of 3.18% [1] Additional Notable Stocks - Other stocks with notable performance include: - Mindray Medical: 4.41% increase, 1.15% turnover [1] - CNOOC Services: 2.70% increase, 0.67% turnover [1] - Qifeng New Materials: 4.08% increase, 4.75% turnover [1]

Market Overview - The Shanghai Composite Index is at 3781.13 points, above the annual line, with a change of 0.40% [1] - The total trading volume of A-shares is 1,193.158 billion yuan [1] Stocks Breaking Annual Line - A total of 31 A-shares have surpassed the annual line today, with notable stocks including Meihua Medical, *ST Aowei, and Pianzaihuang, showing divergence rates of 14.13%, 2.94%, and 2.77% respectively [1] - Stocks with smaller divergence rates that have just crossed the annual line include China Wuyi, Huilun Crystal, and Zhuoshengwei [1] Top Stocks by Divergence Rate - Meihua Medical (301363) has a significant increase of 17.30% with a turnover rate of 23.04% and a divergence rate of 14.13% [1] - *ST Aowei (002231) increased by 3.12% with a turnover rate of 7.79% and a divergence rate of 2.94% [1] - Pianzaihuang (600436) rose by 3.70% with a turnover rate of 1.03% and a divergence rate of 2.77% [1] Additional Notable Stocks - Tongrentang (600085) increased by 1.93% with a divergence rate of 1.77% [1] - Maire Medical (300760) rose by 3.40% with a divergence rate of 1.53% [1] - Other stocks with minor divergence rates include Aima Technology (603529) and China Railway Construction (601186) with divergence rates of 1.06% and 0.96% respectively [1]

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 secretaries earned over 1 million yuan annually, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary for secretaries in the A-share biopharmaceutical sector is 1.01 million yuan [5] - The distribution of salaries is as follows: below 500,000 yuan (15%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (38%), 2,000,000-3,000,000 yuan (4%), and above 3,000,000 yuan (2%) [5] Age and Education Distribution - The age distribution of secretaries shows that those aged 40-50 constitute 61%, while those over 50 account for 15%, and those aged 30-40 make up 18% [1] - In terms of education, 52% of secretaries hold a bachelor's degree, while 44% have a master's degree, and only 2% possess a doctoral degree [3] Investor Engagement - There is significant variation in the number of investor meetings held by companies, with 43% of companies hosting fewer than 10 meetings annually [7] - The top five companies with the highest number of investor meetings are: Bohui Innovation (1,500 meetings), Jindike (777 meetings), Nearshore Protein (681 meetings), Sailun Biotech (549 meetings), and Kanghua Biotech (504 meetings) [9]

Core Insights - The report highlights that the total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - Over 21% of company secretaries earn more than 1 million yuan annually, indicating a significant portion of high earners in this role [1] Salary Distribution - The average annual salary for company secretaries in the biopharmaceutical sector is 1.01 million yuan, with the distribution of salaries as follows: below 500,000 yuan (15%), 500,000-1,000,000 yuan (41%), 1,000,000-2,000,000 yuan (38%), 2,000,000-3,000,000 yuan (4%), and above 3,000,000 yuan (2%) [5] - The top five highest-paid company secretaries have salaries of 3.2565 million yuan, 2.5345 million yuan, 2.2809 million yuan, 1.9265 million yuan, and 1.89 million yuan, with their tenure at the companies ranging from less than one year to 15 years [7] Age and Educational Background - The age distribution of company secretaries shows that those aged 40-50 constitute 61%, while those over 50 account for 15%, and those under 30 make up 6% [1][3] - The educational background indicates that 52% hold a bachelor's degree, 44% have a master's degree, and only 2% possess a doctoral degree, with the latter represented by just one individual [3] Investor Engagement - There is a significant variance in the number of investor meetings held by companies, with 43% of companies hosting fewer than 10 meetings annually, while only 2% have more than 1,000 meetings [9] - The five companies with the highest number of investor meetings are reported to have 1,500, 777, 681, 549, and 504 meetings, respectively [9]